93 related articles for article (PubMed ID: 31170440)
1. Effect of the key histone modifications on the expression of genes related to breast cancer.
Jin W; Li QZ; Liu Y; Zuo YC
Genomics; 2020 Jan; 112(1):853-858. PubMed ID: 31170440
[TBL] [Abstract][Full Text] [Related]
2. Identification of Key Histone Modifications and Their Regulatory Regions on Gene Expression Level Changes in Chronic Myelogenous Leukemia.
Zhang LQ; Fan GL; Liu JJ; Liu L; Li QZ; Lin H
Front Cell Dev Biol; 2020; 8():621578. PubMed ID: 33511133
[TBL] [Abstract][Full Text] [Related]
3. Functional elements demarcated by histone modifications in breast cancer cells.
Choe MK; Hong CP; Park J; Seo SH; Roh TY
Biochem Biophys Res Commun; 2012 Feb; 418(3):475-82. PubMed ID: 22285863
[TBL] [Abstract][Full Text] [Related]
4. Revealing transcription factor and histone modification co-localization and dynamics across cell lines by integrating ChIP-seq and RNA-seq data.
Zhang L; Xue G; Liu J; Li Q; Wang Y
BMC Genomics; 2018 Dec; 19(Suppl 10):914. PubMed ID: 30598100
[TBL] [Abstract][Full Text] [Related]
5. The chromatin remodeling protein BRM regulates the transcription of tight junction proteins: Implication in breast cancer metastasis.
Yang Y; Liu L; Fang M; Bai H; Xu Y
Biochim Biophys Acta Gene Regul Mech; 2019 May; 1862(5):547-556. PubMed ID: 30946989
[TBL] [Abstract][Full Text] [Related]
6. The risk model construction of the genes regulated by H3K36me3 and H3K79me2 in breast cancer.
Wang LY; Zhang LQ; Li QZ; Bai H
Biophys Rep; 2023 Feb; 9(1):45-56. PubMed ID: 37426199
[TBL] [Abstract][Full Text] [Related]
7. Modeling the relationship of epigenetic modifications to transcription factor binding.
Liu L; Jin G; Zhou X
Nucleic Acids Res; 2015 Apr; 43(8):3873-85. PubMed ID: 25820421
[TBL] [Abstract][Full Text] [Related]
8. The hyper-activation of transcriptional enhancers in breast cancer.
Li QL; Wang DY; Ju LG; Yao J; Gao C; Lei PJ; Li LY; Zhao XL; Wu M
Clin Epigenetics; 2019 Mar; 11(1):48. PubMed ID: 30867030
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
Liu L; Gudas LJ
J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002
[TBL] [Abstract][Full Text] [Related]
10. Chromatin interaction analysis reveals changes in small chromosome and telomere clustering between epithelial and breast cancer cells.
Barutcu AR; Lajoie BR; McCord RP; Tye CE; Hong D; Messier TL; Browne G; van Wijnen AJ; Lian JB; Stein JL; Dekker J; Imbalzano AN; Stein GS
Genome Biol; 2015 Sep; 16():214. PubMed ID: 26415882
[TBL] [Abstract][Full Text] [Related]
11. Re-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.
Anisowicz A; Sotiropoulou G; Sager R
Mol Med; 1999 Aug; 5(8):526-41. PubMed ID: 10501656
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors.
Lapierre M; Linares A; Dalvai M; Duraffourd C; Bonnet S; Boulahtouf A; Rodriguez C; Jalaguier S; Assou S; Orsetti B; Balaguer P; Maudelonde T; Blache P; Bystricky K; Boulle N; Cavaillès V
Oncotarget; 2016 Apr; 7(15):19693-708. PubMed ID: 26930713
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic control of phospholipase A2 receptor expression in mammary cancer cells.
Menschikowski M; Hagelgans A; Nacke B; Jandeck C; Sukocheva O; Siegert G
BMC Cancer; 2015 Dec; 15():971. PubMed ID: 26672991
[TBL] [Abstract][Full Text] [Related]
14. Predicting expression: the complementary power of histone modification and transcription factor binding data.
Budden DM; Hurley DG; Cursons J; Markham JF; Davis MJ; Crampin EJ
Epigenetics Chromatin; 2014; 7(1):36. PubMed ID: 25489339
[TBL] [Abstract][Full Text] [Related]
15. Modulation of intracellular iron metabolism by iron chelation affects chromatin remodeling proteins and corresponding epigenetic modifications in breast cancer cells and increases their sensitivity to chemotherapeutic agents.
Pogribny IP; Tryndyak VP; Pogribna M; Shpyleva S; Surratt G; Gamboa da Costa G; Beland FA
Int J Oncol; 2013 May; 42(5):1822-32. PubMed ID: 23483119
[TBL] [Abstract][Full Text] [Related]
16. Cloning and characterization of a novel endothelial promoter of the human CYP19 (aromatase P450) gene that is up-regulated in breast cancer tissue.
Sebastian S; Takayama K; Shozu M; Bulun SE
Mol Endocrinol; 2002 Oct; 16(10):2243-54. PubMed ID: 12351690
[TBL] [Abstract][Full Text] [Related]
17. [IL-8 inhibits the apoptosis of MCF-7 human breast cancer cells by up-regulating Bcl-2 and down-regulating caspase-3].
Pang X; Li K; Wei L; Huang Y; Su M; Wang L; Cao H; Chen T
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Mar; 31(3):307-11. PubMed ID: 25744832
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype.
Li NY; Weber CE; Mi Z; Wai PY; Cuevas BD; Kuo PC
J Am Coll Surg; 2013 Jul; 217(1):17-26; discussion 26. PubMed ID: 23619316
[TBL] [Abstract][Full Text] [Related]
19. Brahma related gene 1 (BRG1) regulates breast cancer cell migration and invasion by activating MUC1 transcription.
Sun L; Yuan Y; Chen J; Ma C; Xu Y
Biochem Biophys Res Commun; 2019 Apr; 511(3):536-543. PubMed ID: 30824191
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the microarray gene expression for breast cancer progression after the application modified logistic regression.
Morais-Rodrigues F; Silv Erio-Machado R; Kato RB; Rodrigues DLN; Valdez-Baez J; Fonseca V; San EJ; Gomes LGR; Dos Santos RG; Vinicius Canário Viana M; da Cruz Ferraz Dutra J; Teixeira Dornelles Parise M; Parise D; Campos FF; de Souza SJ; Ortega JM; Barh D; Ghosh P; Azevedo VAC; Dos Santos MA
Gene; 2020 Feb; 726():144168. PubMed ID: 31759986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
